KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Work In Process (2016 - 2022)

Bio-Rad Laboratories (BIO) has disclosed Work In Process for 14 consecutive years, with $158.8 million as the latest value for Q2 2022.

  • Quarterly Work In Process rose 6.88% to $158.8 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $158.8 million through Jun 2022, up 6.88% year-over-year, with the annual reading at $142.7 million for FY2021, 6.05% down from the prior year.
  • Work In Process for Q2 2022 was $158.8 million at Bio-Rad Laboratories, up from $153.2 million in the prior quarter.
  • The five-year high for Work In Process was $158.8 million in Q2 2022, with the low at $140.9 million in Q2 2018.
  • Average Work In Process over 5 years is $148.4 million, with a median of $148.9 million recorded in 2018.
  • The sharpest move saw Work In Process increased 12.89% in 2018, then dropped 8.17% in 2021.
  • Over 5 years, Work In Process stood at $145.1 million in 2018, then increased by 0.74% to $146.1 million in 2019, then grew by 3.97% to $151.9 million in 2020, then dropped by 6.05% to $142.7 million in 2021, then rose by 11.25% to $158.8 million in 2022.
  • According to Business Quant data, Work In Process over the past three periods came in at $158.8 million, $153.2 million, and $142.7 million for Q2 2022, Q1 2022, and Q4 2021 respectively.